Introduction
============

Edible fungi polysaccharides are a type of active substances that are separated from fruiting bodies, mycelia and fermentation broth of edible and medicinal fungi that serve a role in cell metabolism ([@b1-ol-0-0-11761],[@b2-ol-0-0-11761]). They are natural macromolecule polymers composed of \>10 monosaccharides linked by glycoside bonds ([@b3-ol-0-0-11761]). Previous studies have demonstrated that polysaccharides from edible fungi can have biological activities, such as having antitumor, anti-viral, anti-oxidation and anti-ageing functions, regulating the immune function, improving myocardial protection and lowering blood sugar and lipids ([@b4-ol-0-0-11761]--[@b7-ol-0-0-11761]).

Structure determines function, and therefore the complexity of the polysaccharide structure poses a difficulty in research. Polysaccharides can vary in the arrangement of monosaccharides, which can be linked in numerous ways to form polysaccharides. Additionally, there can be multiple branches at different locations in the main polysaccharide chain, as well as different monosaccharide compositions and connection types on branches ([@b8-ol-0-0-11761]). Furthermore, monosaccharides can form high-level spatial structures ([@b9-ol-0-0-11761]). Therefore, it is of great scientific importance to analyze the structure and activity of polysaccharides.

*Ramaria flaccida (Fr.)* Quél., also known as broom fungi, is a common fungus, belongs to the *Ramariaceae* family. The fruiting bodies are of medium size (height, 2--5 cm; branch thickness, 0.3--0.5 cm), with branches forming dense twigs; stems are short, usually branched from the base of the stipe, and the fungi grow on the deciduous layer or dead branches of the ground in broad-leaved or coniferous forests in summer and autumn ([@b10-ol-0-0-11761]). The fungi contain a variety of carbohydrates, amino acids and trace elements that are beneficial to the human body ([@b7-ol-0-0-11761]). However, research on *Ramaria flaccida (Fr.)* Quél. has been limited to its resource investigation, identification and classification, liquid culture, extraction technology of macromolecule substances and chemical composition ([@b11-ol-0-0-11761],[@b12-ol-0-0-11761]). The fruiting bodies of *Ramaria flaccida (Fr.)* Quél are edible; additionally, this fungus can be used as an indicator of air pollution, which has a great economic value ([@b11-ol-0-0-11761],[@b12-ol-0-0-11761]). To the best of our knowledge, the structure analysis and antitumor activity of pure polysaccharides from *Ramaria flaccida (Fr.)* Quél. have not yet been reported.

In order to identify a novel polysaccharide with good antitumor activity, in the present study purified polysaccharides were obtained from *Ramaria flaccida (Fr.)* Quél. (RF-1) by hot-water extraction, the Sevage method, and by diethylaminoethyl (DEAE)-52 cellulose chromatography. High-performance gel permeation chromatography (HPGPC), gas chromatography-mass spectrometry (GC-MS) and nuclear magnetic resonance (NMR) were used to identify the polysaccharide structure. The antitumor activity of RF-1 was investigated by establishing an *in vivo* S180 tumor model. The transcriptomes of tumor tissues in the blank control group and RF-1 group were sequenced using Illumina sequencing. The present study may help to exploit and utilize the polysaccharide resources from *Ramaria flaccida (Fr.)* Quél., and may provide a theoretical reference for further study of its antitumor mechanism and economic value.

Materials and methods
=====================

### Materials

The fruiting bodies of *Ramaria flaccida (Fr.)* Quél. were collected from the Xiaojin County, Aba Tibetan and Qiang Autonomous Prefecture, Sichuan, China, for which specific permission was not required due to it being an open village in China. The field studies did not involve endangered or protected species, since the endangered or protected species protection zone was not accessed for sampling. DEAE-52 Cellulose Column was purchased from Shenyang Shengxing Biotechnology Co., Ltd. RIPA lysis buffer was purchased from Beyotime Institute of Biotechnology. Anhydrous sodium sulfate and potassium bromide were purchased from Sangon Biotech Co., Ltd. Trifluoroacetic acid, acetonitrile, methanol, iodomethane, chloroform and anhydrous pyridine were purchased from Xuzhou Maoyang Chemical Co., Ltd. The experimental reagents were all analytical reagents. Tumor necrosis factor (TNF)α, interleukin (IL)-6, IL-1β, vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) enzyme-linked immunosorbent assay (ELISA) kits were purchased from R&D Systems China Co., Ltd. The signaling pathways were drawn using Pathway Builder Tool 2.0 (<http://www.proteinlounge.com/PathwayBuilder.aspx>).

### Isolation and extraction of polysaccharides from Ramaria flaccida (Fr.) Quél

The fruiting bodies of *Ramaria flaccida (Fr.)* Quél. were accurately weighed at 500 g. After being dried and crushed, distilled water was added to the fruiting body powder at a ratio of 1:30 (g/ml) and boiled for 3 h in a constant temperature water bath at 100°C. After being centrifuged at 16,670 × g for 15 min at 4°C., the supernatant was collected and concentrated to 200 ml ([@b13-ol-0-0-11761]). Subsequently, the proteins in the concentrated supernatant were removed by the Sevage method ([@b14-ol-0-0-11761]). Finally, 3 times the volume of anhydrous ethanol was added and stirred to produce flocculent precipitates. The crude polysaccharide of *Ramaria flaccida (Fr.)* Quél was obtained by precipitation and dissolved in 200 ml distilled water. A total of 3 ml crude polysaccharide solution was added to a DEAE-52 cellulose column, and 150 ml distilled water was used at a flow rate of 5 ml/min to obtain the eluent. The eluent was concentrated to 5 ml and subsequently lyophilized, after removing small-molecule compounds using dialysis bags ([@b15-ol-0-0-11761]). Finally, the purified polysaccharide of *Ramaria flaccida (Fr.)* Quél was obtained and named RF-1.

### Determination of the molecular weight of RF-1 using HPGPC

The molecular weight of RF-1 was determined using HPGPC, as previously described ([@b16-ol-0-0-11761]). The data are analyzed using the GPC software (Agilent Empower Pro GPC Data Analysis Software for Agilent ChemStation; version B.01.02; Agilent Technologies Inc.). The standard dextran with known molecular weight was used as the molecular weight reference substance of polysaccharide.

### Analysis of RF-1 structure by GC-MS

Samples of polysaccharides were weighed at 25 mg, and 2 ml anhydrous dimethyl sulfoxide was added to fully dissolve them. Subsequently, 400 mg pre-dried sodium hydroxide powder was added, dissolved under ultrasound for 10 min and stirred for 1 h at room temperature. Finally, 1.5 ml iodomethane was added, and 5 ml distilled water was added to terminate the reaction. The product was extracted with chloroform. The methylated polysaccharides were hydrolyzed using trifluoroacetic acid and washed 3 times to obtain the products of complete acid hydrolysis of methylated polysaccharides ([@b17-ol-0-0-11761]). A total of 2 ml anhydrous pyridine, 2 ml hexamethyl-disilazane and 1 ml chlorotrimethylsilane were in turn added to the aforementioned samples. The reaction time was 20 min at 50°C. After centrifugation at 16,670 × g for 20 min at 4°C., the upper solution was used for GC-MS analysis as previously described ([@b18-ol-0-0-11761]).

### NMR analysis

Polysaccharide samples of 10 mg (for ^1^H NMR) and 50 mg (for ^13^C NMR) were collected. After dissolving the samples with 0.5 ml deuterium oxide, the spectra of ^1^H NMR, ^13^C NMR, ^1^H-^1^H correlated spectrometry (^1^H-^1^H COSY), heteronuclear multiple quantum correlation (HMQC) and heteronuclear multiple bond correlation (HMBC) were measured using an NMR spectrometer. Tetramethylsilane was used as an internal standard ([@b19-ol-0-0-11761]). The novelty of polysaccharide structure was analyzed by searching on the SciFinder database ([@b20-ol-0-0-11761]).

### Antitumor activity of RF-1 in vivo

The mouse sarcoma S180 cell line was purchased from The Cell Bank of Type Culture Collection of the Chinese Academy of Sciences. S180 cells were cultured in RPMI-1640 medium (Thermo Fisher Scientific, Inc.) supplemented with 10% inactivated FBS (Invitrogen; Thermo Fisher Scientific, Inc.), 100 µg/ml penicillin and 100 µg/ml streptomycin at 37°C with 5% CO~2~ and were sub-cultured every 2 days. Kunming strain female mice obtained from the Institute of Biochemistry and Molecular Immunology of North Sichuan Medical College (Nanchong, China) were inoculated with 100 µl S180 tumor cells at a concentration of 3×10^6^ CFU/ml under the left axillary skin. The Kunming strain mice (age, 4--6 weeks) weighed 25.0±1.0 g and were divided into three groups, with 5 mice in each group, and 5 mice were housed per plastic cage with wood chip bedding in an animal room with a 12-h light and 12-h dark cycle at room temperature (25±2°C), with free access to standard laboratory diet. After 7 days, each mouse was treated with 20 mg/kg RF-1 (RF-1 group) or 20 mg/kg mannatide (positive control group) for 7 consecutive days ([@b21-ol-0-0-11761]). The mice were sacrificed under anesthesia using 100 mg/kg ketamine and 15 mg/kg xylazine. The respiration, cardiac function, corneal reflex, muscle tone and mucous membrane color were checked to verify the death of the mice in the present study. The following formula was used to calculate tumor volume: V=(length × width^2^)/2 ([@b22-ol-0-0-11761]). The tumor inhibition rate was calculated as follows: Tumor inhibition rate (%)=\[(A-B)/A\] ×100, with A and B being the average tumor weight of the blank control group and treated group, respectively ([@b21-ol-0-0-11761]). The animal experiments were conducted according to the Guidelines for Animal Experimentation of the North Sichuan Medical College of China, which were revised according to the Regulations on the Administration of Experimental Animals of the People\'s Republic of China (decree no. The Second Commission of the People\'s Republic of China of Science and Technology Commission). The experimental protocols were approved by the North Sichuan Medical College of China.

### RNA extraction, library preparation and sequencing

Total RNA of tumor tissues was extracted using the TRIzol^®^ reagent kit (Invitrogen, Thermo Fisher Scientific, Inc.), according to the manufacturer\'s protocol. After the samples were quantified, the library was constructed and checked, and subsequently sequenced using an Illumina Hiseq platform ([@b23-ol-0-0-11761],[@b24-ol-0-0-11761]). Genes with an adjusted P\<0.05 identified by DESeq2 ([@b25-ol-0-0-11761],[@b26-ol-0-0-11761]) were classified as differentially expressed. Subsequently, the clusterProfiler R package ([@b27-ol-0-0-11761]) was used for Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis ([@b27-ol-0-0-11761],[@b28-ol-0-0-11761]). Differentially expressed genes were analyzed using the edgeR program (version 3.11) ([@b29-ol-0-0-11761]).

### Effect of RF-1 on the expression levels of IL-1β, IL-6, TNFα, VEGFR and VEGF in mice tumor tissues

Tumor tissues were cut and collected into 1.5 ml Eppendorf tubes. After adding 300 µl cell lysis solution (Thermo Fisher Scientific, Inc.) containing phosphatase inhibitors (Thermo Fisher Scientific, Inc.) and phenylmethylsulfonyl fluoride to each tube, tissues were ground on ice and beaten into homogenates at 0°C for 30 min. After centrifugation at 16,670 × g at 4°C for 20 min, the supernatant was collected into new tubes. The samples were tested using the IL-1β (cat. no. MAB401), IL-6 (cat. no. DY206), TNFα (cat. no. MAB6902), VEGFR (cat. no. DVR100C) and VEGF (cat. no. 493-MV) ELISA kits.

### Statistical analysis

All data are presented as the mean ± SD (n=5), and SPSS v17 software (SPSS, Inc.) was used to analyze the differences between the blank control group and the experimental groups using one-way ANOVA followed by Dunnett\'s test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Molecular weight analysis of RF-1

As shown in [Fig. 1A](#f1-ol-0-0-11761){ref-type="fig"}, the HPGPC elution curve of RF-1 displayed a symmetrical peak, and the average molecular weight (Mw) of RF-1 was 17,093 Da, the number-average Mw (Mn) was 5,023 Da, the peak Mw (Mp) was 11,313 Da, the Z average Mw (Mz) was 194,421 Da, the Z+1 average Mw (Mz+1) was 129,247 Da and the polydispersity index (D=Mw/Mn) was 3.40 Da. Therefore, the present data indicated that RF-1 is a homogeneous polysaccharide.

### Analysis of the GC-MS experiment results

The GC-MS results of RF-1 ([Table I](#tI-ol-0-0-11761){ref-type="table"} and [Fig. 1B](#f1-ol-0-0-11761){ref-type="fig"}) indicated that the glucopyranose residues were mainly 2,3,4-Me-1,6-substituted, 2,3-Me-1,4,6-substituted and 2,3,6-Me-4-substituted. The glucopyranose residues have 1,6- and 1,4,6-bonding modes and 4-terminal forms. The galactopyranose residues are mainly 3,4-Me-1,2,6-substituted, indicating that galactopyranose residues are 1,2,6-linked. According to the peak area of each monosaccharide in GC-MS, it can be calculated that 1,6-Glu: 1,4,6-Glu: 4-Glu: 1,2,6-Gal=1:1:3:2.

### Analysis of the NMR experiment results

In ^1^H NMR (400 MHz), the chemical shifts of most protons on C2-C6 were in the range of δ3.15-δ4.19, due to the shielding effect of hydroxyl groups. The anomeric protons of polysaccharide fell in the region of δ4.3--5.0 ppm. As shown in [Fig. 2A](#f2-ol-0-0-11761){ref-type="fig"}, RF-1 displayed six heterologous hydrogen signals (δ4.99, δ4.95, δ4.90, δ4.88, δ4.42 and δ4.39). Among them, δ4.99, δ4.95, δ4.90 and δ4.88 were signals of the α-pyranose unit, while the signals of δ4.42 and δ4.39 were in the form of β-pyranose.

In the 95--105 ppm region of the ^13^C NMR (400 MHz) of RF-1, the signal peaks of C~1~ were δ103.01, δ102.92, δ102.44, δ101.35, δ97.95 and δ97.89 ([Fig. 2B](#f2-ol-0-0-11761){ref-type="fig"}). The anomeric carbons in RF-1 displayed α and β heterochromatic configurations. Resonance in the δ101--104 ppm region was attributed to the anomeric carbon atoms of D-glucopyranose. The δ96--101 ppm region was the anomeric carbon atom signal of D-galactopyranose. In the range of δ170--180 ppm, there was no carboxyl resonance signal of alduronic acid, which indicated that RF-1 is a neutral polysaccharide. There was no resonance signal of a furan ring at δ106--109 ppm, suggesting that all monosaccharide residues were in the pyranoid configuration.

^1^H-^1^H COSY is a kind of homonuclear chemical shift correlation spectrum. It refers to the coupling correlation spectrum among protons in the same coupling system. It is mainly used to study the ^1^H homonuclear coupling system ([@b30-ol-0-0-11761]). In the ^1^H-^1^H COSY spectrum of RF-1, there were cross peaks at δ4.99/δ3.78, δ4.95/δ3.71, δ4.90/δ3.75, δ4.88/δ3.71, δ4.42/δ3.24 and δ4.39/δ3.22 ([Fig. 2C](#f2-ol-0-0-11761){ref-type="fig"}). The results of the present study indicated that the H2 shifts of RF-1 were 3.78, 3.71, 3.75, 3.71, 3.24 and 3.22 ppm. According to the chemical shifts of H2, the chemical shifts of H3 can be identified to further detect the chemical shifts of H4-H6. Based on the aforementioned results, the hydrogen signals of monosaccharides in RF-1 in the ^1^H NMR spectra were assigned and listed in [Table II](#tII-ol-0-0-11761){ref-type="table"}.

HMQC reflects the coupling association between directly connected ^1^H and ^13^C nuclei ([@b31-ol-0-0-11761],[@b32-ol-0-0-11761]). After assigning the chemical shifts of the hydrogen nuclei in RF-1 via the ^1^H-^1^H COSY spectrum, the chemical shifts of the carbon nuclei can be assigned via the HMQC spectra. In the HMQC spectrum of RF-1 ([Fig. 2D](#f2-ol-0-0-11761){ref-type="fig"}), there were cross peaks at H1/C1 (4.99/102.44), H1/C1 (4.95/101.35), H1/C1 (4.90/97.95), H1/C1 (4.88/97.89), H1/C1 (4.42/102.92) and H1/C1 (4.39/103.01). Therefore, the chemical shifts of C1-C6 were identified in the HMQC spectrum ([Table II](#tII-ol-0-0-11761){ref-type="table"}).

HMBC reflects information associated with carbon and hydrogen remotely. By associating ^1^H with long-range coupled ^13^C nuclei, structural information of the molecular skeleton can be provided. According to the HMBC spectrum of RF-1 ([Fig. 2E](#f2-ol-0-0-11761){ref-type="fig"}) and the chemical shift attribution table of hydrogen and carbon ([Table II](#tII-ol-0-0-11761){ref-type="table"}), it was identified that A-C6 and B-H4, A-H1 and F-C4, C-H1 and D-C6, C-C6 and D-H1, and C-H2 and E-C4 had correlative coupling associations. This indicated that A and B were connected by 6→4, A and F by 1→4, C and D by 1→6, and C and E by 2→4.

Based on the analysis of the aforementioned experimental results, the RF-1 structure was identified and shown in [Fig. 2F](#f2-ol-0-0-11761){ref-type="fig"}. The main chain of RF-1 consisted of (1→6,2)-α-D-galactopyranose and (1→6,4)-α-D-glucopyranose. One of the branched chains was linked to 4-O of the main glucose chain by (1→6)-α-D-glucopyranose and next linked by one (→4)-β-D-glucopyranose. The other two branched chains were both linked to 2-O of the main glucose chain by one (→4)-β-D-glucopyranose. The structure of the polysaccharide resulted novel by searching the SciFinder database.

### Antitumor activity of RF-1 in vivo

The inhibitory effect of a treatment on tumors is usually judged by the tumor size and the inhibitory rate of the treatment on the tumor. S180 cells are commonly used as cell lines to detect the antineoplastic activity of treatment *in vivo* ([@b32-ol-0-0-11761]). The results from the *in vivo* experiments are shown in [Fig. 3](#f3-ol-0-0-11761){ref-type="fig"} and [Table III](#tIII-ol-0-0-11761){ref-type="table"}. The maximum tumor volume observed in the blank control, RF-1 and mannatide groups was 1.054, 0.618 and 0.545 cm^3^, respectively. The maximum diameter observed in the blank control, RF-1 and mannatide groups was 1.687, 1.482 and 1.398 cm, respectively. Additionally, there was almost no difference in the average liver weight, the average spleen weight and the average thymus weight between the two groups, which indicated that RF-1 did not damage the liver, spleen and thymus ([Table III](#tIII-ol-0-0-11761){ref-type="table"}). The inhibition rate of the treatments in the mouse S180 tumors was 40.00% in the RF-1 group and 53.81% in the mannatide group. The average weight of the tumors in the RF-1 group was 0.58±0.1 g, which was lower than that in the blank control group (0.96±0.20 g), and the average weight of the tumors in the mannatide group was 0.48±0.12 g ([Table III](#tIII-ol-0-0-11761){ref-type="table"}). The present results suggest that RF-1 may have a strong antitumor effect *in vivo*.

### Transcriptome sequencing data

Illumina sequencing technology was used to sequence the transcriptomes of tumor tissues in the blank control and RF-1 groups. After original data filtering, sequence error rate checking and detection of GC content distribution, the clean reads for subsequent analysis were 599,771,500 and 59,981,170 bp in length, respectively (data not shown). After quality control, two groups of clean reads were compared with the reference genome, and the percentage of total annotated genes was 94.51 and 94.3%, respectively, which provides a good basis for the follow-up analysis (data not shown).

### Quantitative analysis of gene expression

The sequencing results revealed that in the blank control group, 12,203 genes were expressed \[fragments per kilobase million (FPKM)≥1\], accounting for 23.18% of the total number of genes, and 1,052 genes were upregulated (FPKM\>60), accounting for 2.00% of the total number of genes. In the RF-1 group, 12,155 genes were expressed, accounting for 23.09% of the total number of genes, and 1,044 genes were upregulated, accounting for 1.98% of the total number of genes. Additionally, there were upregulated genes with different FPKM in the blank control and RF-1 groups. The results revealed that 13 genes \[cytochrome c oxidase subunit 1 (mt-Co1), ribosomal protein lateral stalk subunit P1 (Rplp1), eukaryotic translation elongation factor 1 α 1 (Eef1a1), ribosomal protein L36 (Rpl36), ribosomal protein L34-pseudogene 1 (Rpl34-ps1), galectin 1 (Lgals1), mitochondrion Cytochrome b (mt-Cytb), predicted gene 12191 (Gm12191), NADH-ubiquinone oxidoreductase chain 1 (mt-Nd1), Gm13394, Rpl13, Rpl8 and Rps2-ps10\] were markedly upregulated (FPKM\>2,000) in the blank control group compared with in the RF-1 group ([Table IV](#tIV-ol-0-0-11761){ref-type="table"}), and 13 genes (mt-Co1, Rplp1, Eef1a1, mt-Nd1, Lgals1, Rpl36, mt-Cytb, Gm13394, Gm12191, Rpl34-ps1, Rpl8, Rpl13 and Rps2-ps10) were markedly upregulated (FPKM\>2,000) in the RF-1 group compared with in the blank control group ([Table V](#tV-ol-0-0-11761){ref-type="table"}). Notably, the FPKM of the Rplp1 gene was 4,231.249 in the blank control group and 3,969.035 in the RF-1 group, the FPKM of the Rpl36 gene was 3,290.970 in the blank control group and 2,590.419 in the RF-1 group, and the FPKM of the Rpl34 gene was 2,824.368 in the blank control group and 2,261.856 in the RF-1 group. The present results indicated that Rplp1 was a key gene. RPLP1 interacts with the conservative regions of RPLP0, RPLP2 and 28S rRNA, which forms the main part of the ribosomal GTPase activity center, and can covalently bind to ubiquitin to form fusion proteins and participate in important biological activities ([@b32-ol-0-0-11761]), which was consistent with regulating cell apoptosis and transcription in the RF-1 group of the present study. The Rpl36 gene is directly involved in the synthesis of the ribosomal protein 50S subunit, while the Rpl34 gene belongs to the ribosomal protein L34E family, and is considered to serve an important role in apoptosis, and in the occurrence and development of various malignant tumors ([@b33-ol-0-0-11761],[@b34-ol-0-0-11761]). Previous studies demonstrated that the expression levels of Rpl34 and Rpl36 gene were downregulated in the RF-1 group, indicating that cell mitosis was significantly slowed down, cell proliferation was significantly inhibited, and cell apoptosis was promoted, and that these genes could markedly affect physiological activities in tumor cells ([@b34-ol-0-0-11761],[@b35-ol-0-0-11761]). Although the expression levels of these genes were upregulated in the RF-1 group in the present study, these were lower than those in the blank control group, suggesting that RF-1 may influence the function of some ribosomal subunits in cancer cells, which is consistent with the inhibitory effect of RF-1 on cancer cells *in vivo*.

### Differentially expressed genes between the control and RF-1 groups

By using the edgeR program and using P\<0.05 and \|log~2~ fold-change\|\>2 as the screening criteria ([@b29-ol-0-0-11761]), 1,971 differentially expressed genes were obtained comparing the blank control group with the RF-1 group. Among these, 818 genes were upregulated, whereas 1,153 genes were downregulated ([Fig. 4A](#f4-ol-0-0-11761){ref-type="fig"}). Compared with the blank control group, the top 13 upregulated genes (\|log~2~ fold-change\|\>5) in the RF-1 group included endothelin 2, mucin 15, transcription factor AP-2 β, toll-like receptor 12, BAI1 associated protein 3, α tocopherol transfer protein, claudin 8, TIMP metallopeptidase inhibitor 4, fucosyltransferase 7, hypocretin receptor 1, solute carrier family 28 member 3 (Slc28a3), WNT inhibitory factor 1 (Wif1) and CXXC finger protein 4 (Cxxc4) ([Table VI](#tVI-ol-0-0-11761){ref-type="table"}), while the top 15 downregulated genes (\|log~2~ fold change\|\>6.9) included myosin heavy chain 7 (Myh7), myosin light chain 2 (Myl2), Myh2, Myl3, immunoglobulin heavy variable 3--6 (Ighv3-6), calcium voltage-gated channel auxiliary subunit γ 6 (Cacng6), Slc8a3, immunoglobulin like domain containing receptor 2, leucine rich repeats and transmembrane domains 1, Ighv1-76, γ-aminobutyric acid type A receptor subunit α3, Ighv2-9, Ighv1-72, phospholipase A2 group IVE (Pla2g4e) and immunoglobulin κ chain variable 8--24 ([Table VII](#tVII-ol-0-0-11761){ref-type="table"}).

Wif1, which serves an antagonistic role in the WNT signaling pathway ([@b36-ol-0-0-11761]), was significantly upregulated in the RF-1 group compared with the blank control group. By binding to the WNT ligand, the ligand cannot bind to the cell surface receptor ([@b37-ol-0-0-11761]), thus inhibiting WNT signal transduction. The Wif1 gene was upregulated in the RF-1 group, suggesting that the WNT signaling pathway was one of the key signal transduction pathways in the RF-1 group. At present, research has mainly focused on the antitumor activity of this gene. Additionally, it has been reported that Wif1 can affect the growth of blood vessels and cells in liver tumors ([@b38-ol-0-0-11761]). Cxxc4, another factor that serves an antagonistic role in the WNT signaling pathway, was also upregulated, suggesting that it may serve a key role in the inhibition of tumorigenesis and growth. The protein encoded by this gene binds to the PDZ region of disheveled segment polarity protein 1 (Dvl1), which prevents Dvl1 from forming a complex with Axin ([@b39-ol-0-0-11761]). The aforementioned results and the analysis of the differentially expressed genes suggest that the antitumor activity of RF-1 *in vivo* may be associated with the WNT signaling pathway.

### GO analysis and KEGG analysis of differentially expressed genes

GO is a comprehensive database describing gene function. An adjusted P-value (Padj)\<0.05 was used as the threshold of significant enrichment for GO functional enrichment ([Fig. 4B](#f4-ol-0-0-11761){ref-type="fig"}). A total of 58,807 genes were associated with GO terms; among them, 47,091 were associated with biological processes, 5,250 with cellular components and 6,466 with molecular functions. In the biological processes category, the three terms with the most significant enrichment were 'myofibril assembly' (GO 0030239), 'muscle contraction' (GO 0008038) and 'muscle system process' (GO 0006936). The majority of the terms in the cellular components category were associated with 'contractile fiber' (GO 0043292), 'myofibril' (GO 0030016) and 'sarcomere' (GO 0030017). Under the molecular functions category, the majority of the GO terms were grouped into 'glycosaminoglycan binding' (GO 0005539), 'immunoglobulin receptor binding' (GO 0034987) and 'antigen binding' (GO 0003823). The results indicated that the cytokinetics and immune function of tumor cells in the RF-1 group were different from those in the blank control group.

Padj\<0.05 was used as the threshold of significant enrichment for KEGG pathway enrichment. The results revealed that the WNT ([Fig. 4C](#f4-ol-0-0-11761){ref-type="fig"}) and mitogen-activated protein kinase (MAPK) signaling pathways ([Fig. 4D](#f4-ol-0-0-11761){ref-type="fig"}) were significantly enriched, and the number of differentially expressed genes annotated in these two pathways was 19 and 33, respectively (data not shown). The present result supports the hypothesis that the antineoplastic activity of RF-1 in organisms may be achieved through the WNT and MAPK signaling pathways.

The present analysis identified 19 differentially expressed genes in the WNT signaling pathway, 9 of which were upregulated in the RF-1 group, including Wif1, Cxxc4, Wnt family member 7B (Wnt family member 7B), notum palmitoleoyl-protein carboxylesterase, APC regulator of WNT signaling pathway 2, frizzled class receptor 2, FRAT regulator of WNT signaling pathway 2 and Wnt6, while 10 were downregulated, including secreted frizzled related protein 5 (Sfrp5), calcium/calmodulin dependent protein kinase II α (Camk2a), Camk2b, Sfrp4, Wnt16, VANGL planar cell polarity protein 2, Sfrp1, glypican 4, Sfrp2 and phospholipase C β 1 (data not shown).

Furthermore, out of the 33 differentially expressed genes in the MAPK signaling pathway, 11 were upregulated in the RF-1 group compared with in the control group, including fibroblast growth factor receptor 2, Ras protein specific guanine nucleotide releasing factor 1 (Rasgrf1), Mapk13, calcium voltage-gated channel subunit α1 H (Cacna1h), fibroblast growth factor 10 (Fgf10), growth arrest and DNA damage inducible β (Gadd45b), neurotrophin 5, JunD proto-oncogene AP-1 transcription factor subunit, KIT proto-oncogene receptor tyrosine kinase, dual specificity phosphatase 7 (Dusp7) and nerve growth factor receptor, whereas 22 were downregulated, including Cacng6, Pla2g4e, Cacna1s, Cacng1, Cacna2d1, insulin like growth factor 1, angiopoietin 1, Fgf18, myocyte enhancer factor 2C, Fgf7, TEK receptor tyrosine kinase, Gadd45a, MDS1 and EVI1 complex locus, Vegfd, Cacnb1, interleukin 1 receptor type 1, platelet derived growth factor D (Pdgfd), RAS guanyl releasing protein 3, transforming growth factor β receptor 2), Dusp8, Pdgf receptor α and ribosomal protein S6 kinase A2 (data not shown).

### Expression levels of IL-1β, IL-6, TNFα, VEGFR and VEGF in mice tumor tissues

The expression levels of IL-1β, IL-6, TNFα, VEGFR and VEGF in the blank control group, positive control group and RF-1 group were detected using ELISA kits. The expression levels of IL-1β, IL-6, VEGFR and VEGF in the RF-1 group were significantly downregulated compared with those in the control group (P\<0.01; [Fig. 5](#f5-ol-0-0-11761){ref-type="fig"}).

Discussion
==========

The WNT signaling pathway serves an important role in cell growth, differentiation and apoptosis through classical and non-classical signaling pathways, particularly in its state of abnormal activation in tumor tissues ([@b40-ol-0-0-11761]). In the canonical pathway, the WNT ligand binds to the Frizzled receptor, and the signal is transmitted to the glycogen synthase kinase 3 (GSK-3)/β-Axin-adenomatosis polyposis coli complex, which leads to the accumulation of β-catenin in the cytoplasm and subsequently in the nucleus, resulting in the expression of the lymphoid enhancer-binding factor/T-cell factor-related transcription factors, such as cyclinD1 and c-myc ([@b41-ol-0-0-11761]). RF-1 increased Wif1 expression in the present study. As a secretory antagonist of the WNT signaling pathway, Wif1 can compete with the WNT ligand to bind to the Frizzled receptor and block the WNT signaling pathway ([@b42-ol-0-0-11761]). The increase in Cccx4 expression in the RF-1 group in the present study may inhibit the formation of the complex of DVL1 and Axin by binding to the PDZ region of DVL1, which leads to the continuous phosphorylation of β-catenin in the cytoplasm and makes it difficult to accumulate, thus blocking the activation of the WNT/β-catenin signaling pathway ([@b43-ol-0-0-11761]).

The MEK/ERK-associated intracellular signal transduction pathway is considered to be a classical MAPK signal transduction pathway, which serves a key role in tumorigenesis and metastasis ([@b44-ol-0-0-11761]). Cacna2d1 is a member of the family of α-2/δ subunits and serves important physiological functions, such as contraction, secretion and nerve transmission, by mediating Ca^2+^ into a polarized state ([@b45-ol-0-0-11761]). In the present study, Cacna2d1 expression was downregulated in the RF-1 group. Cacna2d1 expression may affect the state of Ca^2+^ and further increase the expression of Ras protein specific guanine nucleotide releasing factor 1 (RASGRF1) ([@b46-ol-0-0-11761]). RASGRF1 can directly bind to Cdc42, inhibiting the binding of Cdc42 with other guanosine exchange factors, and thus preventing the activation of Cdc42, and inhibiting the invasion and transformation of cancer cells mediated by Cdc42 ([@b46-ol-0-0-11761]). The higher the expression levels of RASGRF1, the stronger the anticancer effect and the lower the risk of cancer growth ([@b47-ol-0-0-11761]).

In addition, phospholipase A2 (PLA2) represents a large group of enzymes that can hydrolyze the structure and function of Sn-2 lipid bonds; it is secreted and released by activated monocytes, macrophages and neutrophils ([@b48-ol-0-0-11761]). In particular, cytoplasmic PLA2 (cPLA2) serves a key role in the network regulation of the expression and activation of a number of inflammatory mediators ([@b49-ol-0-0-11761]). Stimulation of PLA2 expression may serve an important role in reversing malignant phenotypes and in the treatment of cancer. Therefore, the decrease of cPLA2 in the RF-1 group suggests that RF-1 may have anti-inflammatory and antitumor effects. The results of the present study can fully explain the mechanism of the antitumor effect of RF-1.

Finally, IL-1β and IL-6 are important proinflammatory cytokines in inflammatory response ([@b50-ol-0-0-11761],[@b51-ol-0-0-11761]). The expression levels of both cytokines can be used as an index to judge the severity of disease. The expression levels of IL-1β and IL-6 in the RF-1 group were downregulated compared with those in the control group, which indicated that RF-1 may inhibit inflammatory injury in tumor tissues and decrease the levels of IL-1β and IL-6. Neovascularization is an important structural basis for the growth, invasion and metastasis of solid tumors. VEGF mainly binds to VEGFR to activate downstream signaling pathways and promote the growth of tumor vessels. The expression levels of VEGF and VEGFR were downregulated in the RF-1 group, which indicated that RF-1 may have anti-angiogenesis effects on tumors and may therefore inhibit the proliferation of tumor cells.

The polysaccharide from *Ramaria flaccida (Fr.)* Quél. was a homogeneous polysaccharide composed mainly of glucose and galactose with a ratio of 2:1, and was named RF-1. The main chain of RF-1 consisted of (1→6, 2)- α-D-galactopyranose and (1→6, 4)-α-D-glucopyranose. One of the branched chains was linked to 4-O of the main glucose chain by (1→6)-α-D-glucopyranose and next linked by one (→4)-β-D-glucopyranose. The other two branched chains were both linked to 2-O of the main glucose chain by one (→4)-β-D-glucopyranose. RF-1 inhibited the growth of S180 tumors *in vivo*. Using 20 mg/kg RF-1, the inhibition rate of mice S180 tumors was 48.4%. Compared with the blank control group, 1,971 differentially expressed genes were identified, of which 818 were upregulated and 1,153 were downregulated in the RF-1 group. KEGG pathway enrichment analysis revealed that the WNT and MAPK signaling pathways were significantly enriched. The numbers of differentially annotated genes in these two pathways were 19 and 33, respectively. Additionally, ELISA results revealed that the expression levels of IL-1β, IL-6, VEGFR and VEGF were significantly downregulated in the RF-1 group compared with the blank control group. The results of the present study provided a foundation for a deeper investigation of the antitumor effect and mechanism of *Ramaria flaccida (Fr.)* Quél. polysaccharides and a theoretical basis for the research and development of the economic value of *Ramaria flaccida (Fr.)* Quél.
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![(A) Molecular weight determination spectrum of RF-1 by high-performance gel permeation chromatography. (B) Gas chromatography-mass spectrometry analysis of RF-1. RF-1, *Ramaria flaccida (Fr.)* Quél. polysaccharide; Mw, average molecular weight; Mn, number average Mw; MP, peak Mw; Mz, Z average Mw; Mz+1, Z+1 average Mw.](ol-20-03-2169-g00){#f1-ol-0-0-11761}

![(A) The ^1^H NMR spectra of RF-1. (B) The ^13^C NMR spectra of RF-1. (C) ^1^H-^1^H correlated spectrometry spectrum of RF-1. (D) Heteronuclear multiple quantum correlation spectrum of RF-1. (E) Heteronuclear multiple bond correlation spectrum of RF-1. (F) Chemical structure of polysaccharide RF-1. RF-1, *Ramaria flaccida (Fr.)* Quél. polysaccharide; NMR, nuclear magnetic resonance.](ol-20-03-2169-g01){#f2-ol-0-0-11761}

![Antitumor activity of RF-1 *in vivo*. Model, blank control group; RF-1, RF-1 group treated with 20 mg/kg RF-1; Mannatide, positive control group treated with 20 mg/kg mannatide; RF-1, *Ramaria flaccida (Fr.)* Quél. polysaccharide.](ol-20-03-2169-g02){#f3-ol-0-0-11761}

![(A) Volcanic plot of differential gene expression analysis between the blank control group and the RF-1 group. (B) Gene Ontology enrichment analysis of the blank control group and the RF-1 group. (C) Schematic diagram of the WNT signaling pathway. (D) Schematic diagram of the MAPK signaling pathway. BP, biological process; CC, cellular component; MF, molecular function; RF-1, *Ramaria flaccida (Fr.)* Quél. polysaccharide; Padj, adjusted P-value.](ol-20-03-2169-g03){#f4-ol-0-0-11761}

![Effect of RF-1 on the protein levels of (A) IL-1β, (B) IL-6, (C) TNFα, (D) VEGF and (E) VEGFR in tumor tissues. \*\*P\<0.01 vs. control group. IL, interleukin; TNF, tumor necrosis factor; VEGFR, vascular endothelial growth factor receptor; RF-1, *Ramaria flaccida (Fr.)* Quél. Polysaccharide.](ol-20-03-2169-g04){#f5-ol-0-0-11761}

###### 

Gas chromatography-mass spectrometry results of methylation analysis of the *Ramaria flaccida (Fr.)* Quél. polysaccharide.

  Methylated sugar   Linkage   m/z
  ------------------ --------- -----------------------------------------------------------
  2,3,4-Me-1,6-Glc   1,6-      59 73 88 101 117 133 159 185 205 229 265 287 319 351
  2,3-Me-1,4,6-Glc   1,4,6-    73 88 103 133 146 159 191 205 217 247 259 319 361 377 435
  2,3,6-Me-4-Glc     4-        59 73 88 101 133 146 174 207 229 261 293
  3,4-Me-1,2,6-Gal   1,2,6-    73 89 103 133 146 159 205 232 277 317 345 377

###### 

^1^H NMR and ^13^C NMR chemical shifts in the *Ramaria flaccida (Fr.)* Quél. polysaccharide.

                        Chemical shifts, δ, ppm                                                       
  --------------------- ------------------------- ------------ ------------ ------------ ------------ ------------
  A→6)-α-D-Glcp-(1→     4.99/102.44               3.78/60.40   3.56/73.09   3.40/69.45   3.80/68.34   3.56/69.48
  B→4,6)-α-D-Glcp-(1→   4.95/101.35               3.71/66.05   3.47/69.92   3.39/60.88   3.32/66.23   3.19/69.42
  C→2,6)-α-D-Galp-(1→   4.90/97.95                3.75/71.47   3.41/69.20   3.64/67.23   3.52/74.63   3.75/68.65
  D→2,6)-α-D-Galp-(1→   4.88/97.89                3.71/71.76   3.50/66.43   3.39/74.37   3.68/68.32   4.09/69.26
  E-β-D-Glcp-(4→        4.42/102.92               3.24/69.51   3.42/69.45   3.85/68.34   3.56/71.95   4.08/67.06
  F-β-D-Glcp-(4→        4.39/103.01               3.22/75.70   3.51/72.83   3.67/73.34   3.34/75.78   3.25/73.08

NMR, nuclear magnetic resonance.

###### 

Antitumor activities of RF-1 on S180 tumor *in vivo*.

  Group                  Average liver weight, g   Average spleen weight, g   Average thymus weight, g   Average mouse weight, g   Average tumor diameter, cm   Average tumor volume, cm^3^   Average tumor weight, g                                   Tumor inhibition rate, %
  ---------------------- ------------------------- -------------------------- -------------------------- ------------------------- ---------------------------- ----------------------------- --------------------------------------------------------- --------------------------
  Control                1.99±0.25                 0.20±0.02                  0.15±0.02                  29.33±1.93                1.44±0.21                    0.87±0.18                     0.96±0.20                                                 --
  RF-1 (20 mg/kg)        1.96±0.20                 0.18±0.02                  0.12±0.01                  27.63±1.90                1.42±0.04                    0.53±0.09                     0.58±0.1^[a](#tfn2-ol-0-0-11761){ref-type="table-fn"}^    40.00
  Mannatide (20 mg/kg)   2.25±0.29                 0.26±0.05                  0.19±0.09                  30.70±2.75                1.26±0.13                    0.44±0.11                     0.48±0.12^[b](#tfn3-ol-0-0-11761){ref-type="table-fn"}^   53.81

P\<0.05

P\<0.01 vs. control group. RF-1, *Ramaria flaccida (Fr.)* Quél. polysaccharide.

###### 

Quantification of gene expression in the blank control group (FPKM \>2,000).

  Gene ID              FPKM       Gene name   Gene length, bp   Gene biotype                       Gene description
  -------------------- ---------- ----------- ----------------- ---------------------------------- ------------------------------------------------
  ENSMUSG00000064351   5108.05    mt-Co1      1545              Protein coding                     Mitochondrially encoded cytochrome c oxidase I
  ENSMUSG00000007892   4231.249   Rplp1       499               Protein coding                     Ribosomal protein, large, P1
  ENSMUSG00000037742   3449.332   Eef1a1      2493              Protein coding                     Eukaryotic translation elongation factor 1 α 1
  ENSMUSG00000057863   3290.97    Rpl36       404               Protein coding                     Ribosomal protein L36
  ENSMUSG00000068396   2824.368   Rpl34-ps1   354               Processed pseudogene               Ribosomal protein L36
  ENSMUSG00000068220   2782.246   Lgals1      800               Protein coding                     Lectin, galactose binding, soluble 1
  ENSMUSG00000064370   2689.116   mt-Cytb     1144              Protein coding                     Mitochondrially encoded cytochrome b
  ENSMUSG00000083061   2613.918   Gm12191     348               Processed pseudogene               Predicted gene 12191
  ENSMUSG00000064341   2495.384   mt-Nd1      957               Protein coding                     Mitochondrially encoded NADH dehydrogenase 1
  ENSMUSG00000083773   2243.619   Gm13394     1000              Processed pseudogene               Predicted gene 13394
  ENSMUSG00000000740   2200.529   Rpl13       2595              Protein coding                     ribosomal protein L13
  ENSMUSG00000003970   2166.688   Rpl8        862               Protein coding                     ribosomal protein L8
  ENSMUSG00000091957   2162.028   Rps2-ps10   965               Transcribed processed pseudogene   ribosomal protein S2, pseudogene 10

FPKM, fragments per kilobase million.

###### 

Quantification of gene expression in the *Ramaria flaccida (Fr.)* Quél. polysaccharide group (FPKM \>2,000).

  Gene ID              FPKM       Gene name   Gene length, bp   Gene biotype                       Gene description
  -------------------- ---------- ----------- ----------------- ---------------------------------- ------------------------------------------------
  ENSMUSG00000064351   6474.749   mt-Co1      1545              Protein coding                     Mitochondrially encoded cytochrome c oxidase I
  ENSMUSG00000007892   3969.035   Rplp1       499               Protein coding                     Ribosomal protein, large, P1
  ENSMUSG00000037742   3079.388   Eef1a1      2493              Protein coding                     Eukaryotic translation elongation factor 1 α 1
  ENSMUSG00000064341   2940.164   mt-Nd1      957               Protein coding                     Mitochondrially encoded NADH dehydrogenase 1
  ENSMUSG00000068220   2762.111   Lgals1      800               Protein coding                     Lectin, galactose binding, soluble 1
  ENSMUSG00000057863   2590.419   Rpl36       404               Protein coding                     Ribosomal protein L36
  ENSMUSG00000064370   2471.775   mt-Cytb     1144              Protein coding                     Mitochondrially encoded cytochrome b
  ENSMUSG00000083773   2297.863   Gm13394     1000              Processed pseudogene               Predicted gene 13394
  ENSMUSG00000083061   2274.003   Gm12191     348               Processed pseudogene               Predicted gene 12191
  ENSMUSG00000068396   2261.856   Rpl34-ps1   354               Processed pseudogene               Ribosomal protein L34, pseudogene 1
  ENSMUSG00000003970   2137.731   Rpl8        862               Protein coding                     Ribosomal protein L8
  ENSMUSG00000000740   2122.002   Rpl13       2595              Protein coding                     Ribosomal protein L13
  ENSMUSG00000091957   2051.634   Rps2-ps10   965               Transcribed processed pseudogene   Ribosomal protein S2, pseudogene 10

FPKM, fragments per kilobase million.

###### 

Differentially expressed (upregulated) genes between the blank control group and the *Ramaria flaccida (Fr.)* Quél. polysaccharide group (\|log~2~ fold-change\|\>5).

  Gene ID              Log~2~ fold-change   Gene name   Gene length, bp   Gene biotype     Gene description
  -------------------- -------------------- ----------- ----------------- ---------------- ----------------------------------------------------------------------------
  ENSMUSG00000028635   8.997284             Edn2        1462              Protein coding   Endothelin 2
  ENSMUSG00000050808   8.752694             Muc15       3569              Protein coding   Mucin 15
  ENSMUSG00000025927   8.552894             Tfap2b      6338              Protein coding   Transcription factor AP-2 β
  ENSMUSG00000062545   8.208796             Tlr12       3177              Protein coding   Toll-like receptor 12
  ENSMUSG00000047507   7.954483             Baiap3      5112              Protein coding   BAI1-associated protein 3
  ENSMUSG00000073988   7.645538             Ttpa        3488              Protein coding   Tocopherol (α) transfer protein
  ENSMUSG00000050520   7.092531             Cldn8       2356              Protein coding   Claudin 8
  ENSMUSG00000030317   6.814687             Timp4       5894              Protein coding   Tissue inhibitor of metalloproteinase 4
  ENSMUSG00000036587   6.814687             Fut7        2355              Protein coding   Fucosyltransferase 7
  ENSMUSG00000028778   6.814687             Hcrtr1      2608              Protein coding   Hypocretin (orexin) receptor 1
  ENSMUSG00000021553   6.814687             Slc28a3     7902              Protein coding   Solute carrier family 28 (sodium-coupled nucleoside transporter), member 3
  ENSMUSG00000020218   6.814687             Wif1        2427              Protein coding   Wnt inhibitory factor 1
  ENSMUSG00000044365   5.609282             Cxxc4       13401             Protein coding   CXXC finger 4

###### 

Differentially expressed (downregulated) genes between the blank control group and the *Ramaria flaccida (Fr.)* Quél. polysaccharide group (\|log~2~ fold-change\|\>6.9).

  Gene ID              Log~2~ fold-change   Gene name   Gene length, bp   Gene biotype     Gene description
  -------------------- -------------------- ----------- ----------------- ---------------- --------------------------------------------------------------
  ENSMUSG00000053093   9.972783629          Myh7        8586              Protein coding   Myosin, heavy polypeptide 7, cardiac muscle, β
  ENSMUSG00000013936   8.915444458          Myl2        1950              Protein coding   Myosin, light polypeptide 2, regulatory, cardiac, slow
  ENSMUSG00000033196   8.800023105          Myh2        7137              Protein coding   Myosin, heavy polypeptide 2, skeletal muscle, adult
  ENSMUSG00000059741   8.653007497          Myl3        2044              Protein coding   Myosin, light polypeptide 3
  ENSMUSG00000076672   8.295564025          Ighv3-6     350               IG V gene        Immunoglobulin heavy variable 3--6
  ENSMUSG00000078815   8.219863343          Cacng6      1977              Protein coding   Calcium channel, voltage-dependent, γ subunit 6
  ENSMUSG00000079055   8.180469388          Slc8a3      5332              Protein coding   Solute carrier family 8 (sodium/calcium exchanger), member 3
  ENSMUSG00000040612   7.965542551          Ildr2       8251              Protein coding   Immunoglobulin-like domain containing receptor 2
  ENSMUSG00000045776   7.819319431          Lrtm1       7939              Protein coding   Leucine-rich repeats and transmembrane domains 1
  ENSMUSG00000093896   7.536914365          Ighv1-76    368               IG V gene        Immunoglobulin heavy variable 1--76
  ENSMUSG00000031343   7.473137098          Gabra3      3924              Protein coding   γ-aminobutyric acid A receptor, subunit α 3
  ENSMUSG00000096638   7.336445309          Ighv2-9     362               IG V gene        Immunoglobulin heavy variable 2--9
  ENSMUSG00000096074   7.103554472          Ighv1-72    396               IG V gene        Immunoglobulin heavy variable 1--72
  ENSMUSG00000050211   6.924380268          Pla2g4e     6960              Protein coding   Phospholipase A2, group IVE
  ENSMUSG00000076583   6.924380268          Igkv8-24    365               IG V gene        Immunoglobulin κ chain variable 8--24

[^1]: Contributed equally
